T1	Disorder 25 31	anemia
N1 	Reference T1 UMLS:C0002871	anemia
T2	Disorder 50 68	pemphigus vulgaris
N2 	Reference T2 UMLS:C0030809	pemphigus vulgaris
T3	Pharmacological_substance 91 112	mycophenolate mofetil
N1000 	Reference T3 MeSH:D009173	mycophenolate mofetil
T4	Pharmacological_substance 117 127	prednisone
N1001 	Reference T4 MeSH:D011241	prednisone
T5	Pharmacological_substance 130 151	Mycophenolate mofetil
N1002 	Reference T5 MeSH:D009173	Mycophenolate mofetil
T6	Pharmacological_substance 164 186	immunosuppressive drug
N1003 	Reference T6 MeSH:D007166	immunosuppressive drug
N1004 	Reference T6 MeSH:D007166	immunosuppressive drug
T7	Disorder 218 233	lupus nephritis
N3 	Reference T7 UMLS:C0024143	lupus nephritis
T8	Disorder 238 256	pemphigus vulgaris
N4 	Reference T8 UMLS:C0030809	pemphigus vulgaris
T9	Pharmacological_substance 325 335	prednisone
N1005 	Reference T9 MeSH:D011241	prednisone
T10	Disorder 345 363	pemphigus vulgaris
N5 	Reference T10 UMLS:C0030809	pemphigus vulgaris
T11	Disorder 402 408	anemia
N6 	Reference T11 UMLS:C0002871	anemia
T13	Pharmacological_substance 518 528	prednisone
N1006 	Reference T13 MeSH:D011241	prednisone
T17	Pharmacological_substance 977 992	corticosteroids
N1007 	Reference T17 MeSH:D000305	corticosteroids
T18	Pharmacological_substance 994 1006	cyclosporine
N1008 	Reference T18 MeSH:D016572	cyclosporine
T20	Disorder 1050 1056	anemia
N7 	Reference T20 UMLS:C0002871	anemia
T22	Disorder 1130 1136	anemia
N8 	Reference T22 UMLS:C0002871	anemia
T23	Disorder 1186 1195	pemphigus
N9 	Reference T23 UMLS:C0030807	pemphigus
T24	Disorder 1223 1229	anemia
N10 	Reference T24 UMLS:C0002871	anemia
T25	Pharmacological_substance 1288 1298	prednisone
N1009 	Reference T25 MeSH:D011241	prednisone
T26	Pharmacological_substance 1400 1412	cyclosporine
N1010 	Reference T26 MeSH:D016572	cyclosporine
T27	Pharmacological_substance 1417 1427	prednisone
N1011 	Reference T27 MeSH:D011241	prednisone
T28	Pharmacological_substance 1669 1681	azathioprine
N1012 	Reference T28 MeSH:D001379	azathioprine
T29	Pharmacological_substance 1718 1730	azathioprine
N1013 	Reference T29 MeSH:D001379	azathioprine
T30	Pharmacological_substance 152 156	(MMF
N1014 	Reference T30 MeSH:D009173	(MMF
T12	Pharmacological_substance 316 319	MMF
N1015 	Reference T12 MeSH:D009173	MMF
T14	Pharmacological_substance 1008 1011	MMF
N1016 	Reference T14 MeSH:D009173	MMF
T31	Pharmacological_substance 1395 1398	MMF
N1017 	Reference T31 MeSH:D009173	MMF
T32	Pharmacological_substance 1173 1176	MMF
N1018 	Reference T32 MeSH:D009173	MMF
T33	Subject 35 44	a patient
T35	Combination 113 116	and
T36	Disorder 195 216	renal transplantation
N11 	Reference T36 UMLS:C0042075	renal transplantation
T39	Combination 320 324	with
T41	Pharmacological_substance 451 454	MMF
N1019 	Reference T41 MeSH:D009173	MMF
T42	Subject 888 912	four transplant patients
T43	Pharmacological_substance 1017 1043	anti-T-lymphocyte globulin
T46	Combination 968 976	utilized
T15	Disorder 673 705	total aplasia of red blood cells
T16	Pharmacological_substance 1247 1250	MMF
N1020 	Reference T16 MeSH:D009173	MMF
T21	Combination 1380 1391	combination
T48	Disorder 1337 1352	transplantation
N12 	Reference T48 UMLS:C0478647	transplantation
T50	Pharmacological_substance 1581 1584	MMF
N1021 	Reference T50 MeSH:D009173	MMF
T51	Pharmacological_substance 1531 1534	MMF
N1022 	Reference T51 MeSH:D009173	MMF
T52	Subject 257 265	patients
T54	Subject 1157 1165	patients
T58	Pharmacological_substance 815 818	MMF
N1023 	Reference T58 MeSH:D009173	MMF
T65	Negation_cue 1115 1118	not
T66	Speculation_cue 1230 1233	can
T68	Combination 1277 1287	given with
